Cindy Reiss Clark is Chief Commercial Officer of WEST PHARMACEUTICAL SERVICES INC. Currently has a direct ownership of 4,884 shares of WST, which is worth approximately $1.55 Million. The most recent transaction as insider was on Feb 20, 2024, when has been sold 551 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.88K
0% 3M change
13.06% 12M change
Total Value Held $1.55 Million

Cindy Reiss-Clark Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
BUY
Grant, award, or other acquisition
-
551 Added 10.14%
4,884 Common Stock
Aug 22 2023
SELL
Open market or private sale
$1,367,643 $393.34 p/Share
3,477 Reduced 44.59%
4,320 Common Stock
Aug 22 2023
BUY
Exercise of conversion of derivative security
$946,474 $272.21 p/Share
3,477 Added 30.84%
7,797 Common Stock
Feb 21 2023
BUY
Grant, award, or other acquisition
$297,479 $306.68 p/Share
970 Added 18.34%
4,320 Common Stock
CR

Cindy Reiss Clark

Chief Commercial Officer
Exton, PA

Track Institutional and Insider Activities on WST

Follow WEST PHARMACEUTICAL SERVICES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WST shares.

Notify only if

Insider Trading

Get notified when an West Pharmaceutical Services Inc insider buys or sells WST shares.

Notify only if

News

Receive news related to WEST PHARMACEUTICAL SERVICES INC

Track Activities on WST